a2 Milk Company Ltd.
12
1
1
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 12 trials
100.0%
+13.5% vs industry average
33%
4 trials in Phase 3/4
0%
0 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Milk Free From A1-Type β-Casein on Inflammation, Gastrointestinal Tolerance, and Pregnancy Outcomes
Role: lead
A1 Beta-casein-free Milk in Milk-intolerant Participants
Role: lead
Investigate Effects of A2 Milk on Breastmilk Composition and Subsequent Infant Gut Health, Crying and Sleep Patterns in Healthy, Full-term Infants
Role: lead
Comparative Effects of A2 Platinum Stage 1 Infant Formula on Infant Digestion and Comfort
Role: lead
Improved Respiratory Infection by Consuming Lactoferrin Fortified a2 Growing up Formula in Children of 2 to 3 Year Old
Role: lead
The Effects of a2 Infant Formula on Growth and Tolerance in Healthy Term Infants
Role: lead
Comparative Effects of a2 Skim Milk on Mild Cognitive Impairment in Older Adults
Role: lead
a2 Milk for Autism and Attention-deficit Hyperactivity Disorder (ADHD)
Role: collaborator
Comparative A1 vs A2 Formula and Breast Feeding on Alimentation and Gastrointestinal Digestion for the Infant
Role: lead
A1 Versus A2® Milk on the Gastrointestinal Physiology, Symptoms and Cognitive Behaviour for the Preschool Children
Role: lead
Incidence of Lactose Intolerance Among Self-reported Lactose Intolerant People
Role: lead
Effects Comparison of A1 and A2 Milk on Gastrointestinal Physiology, Symptoms and Cognitive Behavior
Role: lead
All 12 trials loaded